Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 2/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | AHR | P35869 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 7/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | CASP7 | P55210 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21236415 | 0.97 | LPL (0.40) | LPLLIPGPGRAHRMAPT | |
| SCHEMBL23730994 | 0.94 | PGR (0.39) | LPLLIPGPGRAHRMAPT | |
| SCHEMBL23105616 | 0.85 | LPL (0.38) | LPLLIPGPGRAHRMAPT | |
| SCHEMBL31643463 | 0.85 | LPL (0.38) | LPLLIPGPGRAHRMAPT | |
| SCHEMBL24841672 | 0.82 | LPL (0.41) | LPLLIPGPGRAHRMAPT | |
| SCHEMBL25871494 | 0.82 | LIPG (0.55) | LPLLIPGAHRMAPTKMT2A | |
| SCHEMBL25582666 | 0.82 | LPL (0.41) | LPLLIPGAHRMAPTKMT2A | |
| SCHEMBL21891288 | 0.82 | ALOX5 (0.36) | LPLLIPGMAPTKMT2AMEN1 | |
| SCHEMBL21926365 | 0.82 | LPL (0.37) | LPLLIPGPGRAHRMAPT | |
| SCHEMBL21926811 | 0.82 | LPL (0.35) | LPLLIPGMAPTKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11081655-B2 | Heterocyclic compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2021-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11081655-B2 | Heterocyclic compound and organic light emitting device using the same | CRY1, CYP1B1, CYBA | LPL 3290/4885LIPG 3000/4885PGR 2744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.